Changes of thrombelastography in patients undergoing elective primary total knee and total hip replacement with low molecular heparin prophylaxis

Journal of Orthopaedic Surgery and Research

Volumn 9, Issue 1, 2014, Pages

  Yang, Yi ^a   Yao, Zhenjun ^a   Dai, Wenda ^a   Shi, Peng ^b   luo, Lei ^a   Zhang, Chi ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Arthroplasty; Hypercoagulability; Low molecular weight heparin; Thrombelastography; Thromboprophylaxis

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ELECTIVE SURGERY; FEMALE; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; THROMBOELASTOGRAPHY; THROMBOPHILIA; VENOUS THROMBOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; ELECTIVE SURGICAL PROCEDURES; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; THROMBELASTOGRAPHY; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 84904082576     PISSN: None     EISSN: 1749799X     Source Type: Journal    
DOI: 10.1186/s13018-014-0052-0     Document Type: Article

References (23)

1. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH: A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am 2000, 82-A(7):929-938.
2. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr; American College of Chest Physicians: Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(2 Suppl):e278S-e325S.
3. Mont MA, Jacobs JJ, Boggio LN, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, Yates AJ Jr, Watters WC 3rd, Turkelson CM, Wies JL, Donnelly P, Patel N, Sluka P, AAOS: Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg 2011, 19(12):768-776.
4. Bloomfield MR, Patterson RW, Froimson MI: Complications of anticoagulation for thromboembolism in early postoperative total joint arthroplasty. Am J Orthop (Belle Mead NJ) 2011, 40(8):E148-E151.
5. Rafiq S, Johansson PI, Ostrowski SR, Stissing T, Steinbrüchel DA: Hypercoagulability in patients undergoing coronary artery bypass grafting: prevalence, patient characteristics and postoperative outcome. Eur J Cardiothorac Surg 2012, 41(3):550-555.
6. Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Størkson R, Hervig T: Thrombelastography. Transfus Apher Sci 2009, 40(2):119-123.
7. Kouerinis IA, Kourtesis A, El-Ali M, Sergentanis T, Plagou A, Argiriou M, Theakos N, Giannakopoulou A: Heparin induced thrombocytopenia diagnosis in cardiac surgery: is there a role for thromboelastography? Interact Cardiovasc Thorac Surg 2008, 7(4):560-563.
8. Gonzalez E, Kashuk JL, Moore EE, Silliman CC: Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta ({increment}). J Surg Res 2010, 163(1):96-101.
9. Hepner DL, Concepcion M, Bhavani-Shankar K: Coagulation status using thromboelastography in patients receiving warfarin prophylaxis and epidural analgesia. J Clin Anesth 2002, 14(6):405-410.
10. Wilson D, Cooke EA, McNally MA, Wilson HK, Yeates A, Mollan RA: Changes in coagulability as measured by thromboelastography following surgery for proximal femoral fracture. Injury 2001, 32:7650.
11. Muntz J: Thromboprophylaxis in orthopedic surgery: how long is long enough? Am J Orthop (Belle Mead NJ) 2009, 38(8):394-401.
12. Martinelli I, Bucciarelli P, Mannucci PM: Thrombotic risk factors: basic pathophysiology. Crit Care Med 2010, 38(2 Suppl):S3-S9.
13. Kashuk JL, Moore EE, Sabel A, Barnett C, Haenel J, Le T, Pezold M, Lawrence J, Biffl WL, Cothren CC, Johnson JL: Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery 2009, 146(4):764-772.
14. Patel R, Cook DJ, Meade MO, Griffith LE, Mehta G, Rocker GM, Marshall JC, Hodder R, Martin CM, Heyland DK, Peters S, Muscedere J, Soth M, Campbell N, Guyatt GH; Burden of Illness in venous ThromboEmbolism in Critical care (BITEC) Study Investigators; Canadian Critical Care Trials Group: Burden of illness in venous thromboembolism in critical care: a multicenter observational study. J Crit Care 2005, 20:341-347.
15. Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, Kheirabadi BS, Pusateri AE, Vos JA, Guymon CH, Wolf SE, Mann KG, Holcomb JB: Thromboelastography as a better indicator of postinjury hypercoagulable state than prothrombin time or activated partial thromboplastin time. J Trauma 2009, 67(2):266-276.
16. Dai Y, Lee A, Critchley LA, White PF: Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg 2009, 108(3):734-742.
17. Rafiq S, Johansson PI, Zacho M, Stissing T, Kofoed K, Lilleør NB, Steinbrüchel DA: Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial. Trials 2012, 13:48.
18. Lowe GDO: Common risk factors for both arterial and venous thrombosis. Br J Haematol 2008, 140:488-495.
19. López JA, Kearon C, Lee AY: Deep venous thrombosis. Hematology Am Soc Hematol Educ Program 2004, 2004(1):439-456.
20. Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, Horstman LL, Soriano AO, Zambrano JP, Ahn YS: Elevation of endotheial microparticles, platelet, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005, 45(9):1467-1471.
21. Takahashi M, Yamashita A, Moriguchi-Goto S, Marutsuka K, Sato Y, Yamamoto H, Koshimoto C, Asada Y: Critical role of von Willebrand factor and platelet interaction in venous thromboembolism. Histo Histopathol 2009, 24(11):1391-1398.
22. Myers DD Jr, Rectenwald JE, Bedard PW, Kaila N, Shaw GD, Schaub RG, Farris DM, Hawley AE, Wrobleski SK, Henke PK, Wakefield TW: Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg 2005, 42:329-336.
23. Bozic KJ, Vail TP, Pekow PS, Maselli JH, Lindenauer PK, Auerbach AD: Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty 2010, 25(7):1053-1060.